Hepcidin levels in hyperprolactinemic women monitored by nanopore thin film based assay

Correlation with pregnancy-associated hormone prolactin

Jing Wang, Gang Liu, Zi Xu, Jiwei Dai, Ping Song, Jian Shi, Ye Hu, Zhongbo Hu, Guangjun Nie, Yan zhong Chang, Yuliang Zhao

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Hepcidin is a central regulator in human iron metabolism. Although it is often regarded as a promising indicator of iron status, the lack of effective quantification method has impeded the comprehensive assessment of its physiological and clinical significance. Herein we applied a newly established, nanopore film enrichment based hepcidin assay to examine the correlation between hepcidin and prolactin, the hormone with an important role during pregnancy and lactation. Women with pathologically elevated prolactin secretion (hyperprolactinemia) were found to have lower serum hepcidin compared to those with normal prolactin levels, without showing significant difference in other hepcidin-regulating factors. Moreover, prolactin-reducing drug bromocriptine mesylate resulted in elevated expression of the hepcidin in hyperprolactinemia patients. These findings suggest a possible role of prolactin in regulation of hepcidin, and may render hepcidin a useful biomarker for progress monitoring and treatment of iron-related diseases under hyperprolactinemic conditions. From the Clinical Editor: The level of hepcidin has been shown to reflect the underlying iron status of the patient. Nonentheless, there is an urgent need of reliable, fast and easy-to-do hepcidin assay in the clinical setting. In this paper, the authors described a further modification of their previously described nanopore silica film-based enrichment approach for quantification of hepcidin and found correlation between hepcidin and prolactin. This new knowledge may add to current understanding of iron homeostasis during pregnancy.

Original languageEnglish (US)
Pages (from-to)871-878
Number of pages8
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume11
Issue number4
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Nanopores
Hepcidins
Hormones
Prolactin
Assays
Iron
Thin films
Pregnancy
Biomarkers
Hyperprolactinemia
Metabolism
Silica
Monitoring
Bromocriptine
Lactation
Silicon Dioxide

Keywords

  • Biomarker
  • Hepcidin
  • Hyperprolactinemia
  • MALDI-TOF MS
  • Nanopore silica film
  • Prolactin

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Hepcidin levels in hyperprolactinemic women monitored by nanopore thin film based assay : Correlation with pregnancy-associated hormone prolactin. / Wang, Jing; Liu, Gang; Xu, Zi; Dai, Jiwei; Song, Ping; Shi, Jian; Hu, Ye; Hu, Zhongbo; Nie, Guangjun; Chang, Yan zhong; Zhao, Yuliang.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 11, No. 4, 01.01.2015, p. 871-878.

Research output: Contribution to journalArticle

Wang, Jing ; Liu, Gang ; Xu, Zi ; Dai, Jiwei ; Song, Ping ; Shi, Jian ; Hu, Ye ; Hu, Zhongbo ; Nie, Guangjun ; Chang, Yan zhong ; Zhao, Yuliang. / Hepcidin levels in hyperprolactinemic women monitored by nanopore thin film based assay : Correlation with pregnancy-associated hormone prolactin. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2015 ; Vol. 11, No. 4. pp. 871-878.
@article{202a7304f2a740809b508136179e300f,
title = "Hepcidin levels in hyperprolactinemic women monitored by nanopore thin film based assay: Correlation with pregnancy-associated hormone prolactin",
abstract = "Hepcidin is a central regulator in human iron metabolism. Although it is often regarded as a promising indicator of iron status, the lack of effective quantification method has impeded the comprehensive assessment of its physiological and clinical significance. Herein we applied a newly established, nanopore film enrichment based hepcidin assay to examine the correlation between hepcidin and prolactin, the hormone with an important role during pregnancy and lactation. Women with pathologically elevated prolactin secretion (hyperprolactinemia) were found to have lower serum hepcidin compared to those with normal prolactin levels, without showing significant difference in other hepcidin-regulating factors. Moreover, prolactin-reducing drug bromocriptine mesylate resulted in elevated expression of the hepcidin in hyperprolactinemia patients. These findings suggest a possible role of prolactin in regulation of hepcidin, and may render hepcidin a useful biomarker for progress monitoring and treatment of iron-related diseases under hyperprolactinemic conditions. From the Clinical Editor: The level of hepcidin has been shown to reflect the underlying iron status of the patient. Nonentheless, there is an urgent need of reliable, fast and easy-to-do hepcidin assay in the clinical setting. In this paper, the authors described a further modification of their previously described nanopore silica film-based enrichment approach for quantification of hepcidin and found correlation between hepcidin and prolactin. This new knowledge may add to current understanding of iron homeostasis during pregnancy.",
keywords = "Biomarker, Hepcidin, Hyperprolactinemia, MALDI-TOF MS, Nanopore silica film, Prolactin",
author = "Jing Wang and Gang Liu and Zi Xu and Jiwei Dai and Ping Song and Jian Shi and Ye Hu and Zhongbo Hu and Guangjun Nie and Chang, {Yan zhong} and Yuliang Zhao",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.nano.2015.01.008",
language = "English (US)",
volume = "11",
pages = "871--878",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Hepcidin levels in hyperprolactinemic women monitored by nanopore thin film based assay

T2 - Correlation with pregnancy-associated hormone prolactin

AU - Wang, Jing

AU - Liu, Gang

AU - Xu, Zi

AU - Dai, Jiwei

AU - Song, Ping

AU - Shi, Jian

AU - Hu, Ye

AU - Hu, Zhongbo

AU - Nie, Guangjun

AU - Chang, Yan zhong

AU - Zhao, Yuliang

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Hepcidin is a central regulator in human iron metabolism. Although it is often regarded as a promising indicator of iron status, the lack of effective quantification method has impeded the comprehensive assessment of its physiological and clinical significance. Herein we applied a newly established, nanopore film enrichment based hepcidin assay to examine the correlation between hepcidin and prolactin, the hormone with an important role during pregnancy and lactation. Women with pathologically elevated prolactin secretion (hyperprolactinemia) were found to have lower serum hepcidin compared to those with normal prolactin levels, without showing significant difference in other hepcidin-regulating factors. Moreover, prolactin-reducing drug bromocriptine mesylate resulted in elevated expression of the hepcidin in hyperprolactinemia patients. These findings suggest a possible role of prolactin in regulation of hepcidin, and may render hepcidin a useful biomarker for progress monitoring and treatment of iron-related diseases under hyperprolactinemic conditions. From the Clinical Editor: The level of hepcidin has been shown to reflect the underlying iron status of the patient. Nonentheless, there is an urgent need of reliable, fast and easy-to-do hepcidin assay in the clinical setting. In this paper, the authors described a further modification of their previously described nanopore silica film-based enrichment approach for quantification of hepcidin and found correlation between hepcidin and prolactin. This new knowledge may add to current understanding of iron homeostasis during pregnancy.

AB - Hepcidin is a central regulator in human iron metabolism. Although it is often regarded as a promising indicator of iron status, the lack of effective quantification method has impeded the comprehensive assessment of its physiological and clinical significance. Herein we applied a newly established, nanopore film enrichment based hepcidin assay to examine the correlation between hepcidin and prolactin, the hormone with an important role during pregnancy and lactation. Women with pathologically elevated prolactin secretion (hyperprolactinemia) were found to have lower serum hepcidin compared to those with normal prolactin levels, without showing significant difference in other hepcidin-regulating factors. Moreover, prolactin-reducing drug bromocriptine mesylate resulted in elevated expression of the hepcidin in hyperprolactinemia patients. These findings suggest a possible role of prolactin in regulation of hepcidin, and may render hepcidin a useful biomarker for progress monitoring and treatment of iron-related diseases under hyperprolactinemic conditions. From the Clinical Editor: The level of hepcidin has been shown to reflect the underlying iron status of the patient. Nonentheless, there is an urgent need of reliable, fast and easy-to-do hepcidin assay in the clinical setting. In this paper, the authors described a further modification of their previously described nanopore silica film-based enrichment approach for quantification of hepcidin and found correlation between hepcidin and prolactin. This new knowledge may add to current understanding of iron homeostasis during pregnancy.

KW - Biomarker

KW - Hepcidin

KW - Hyperprolactinemia

KW - MALDI-TOF MS

KW - Nanopore silica film

KW - Prolactin

UR - http://www.scopus.com/inward/record.url?scp=84929299205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929299205&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2015.01.008

DO - 10.1016/j.nano.2015.01.008

M3 - Article

VL - 11

SP - 871

EP - 878

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 4

ER -